Evolution of Antimicrobial Resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in Romania: A Narrative Review of Published Data (2001-2024)
Abstract
Antimicrobial resistance constitutes a major global public health challenge, with Romania among the European countries affected. Acinetobacter baumannii and Pseudomonas aeruginosa was designated by the World Health Organization (WHO) as priority pathogens, are frequently implicated in healthcare-associated infections (HAIs), including pneumonia, surgical site infections, urinary tract infections, and bacteremia. We have narratively synthesized surveillance studies published in different regions of Romania, encompassing date whit the period 2001-2024. A total of 13 studies reporting data on P. aeruginosa (2003-2024) and 15 studies on A. baumannii (2001-2024) were included. The strains were isolated from various pathological products, including urine, sputum, tracheobronchial aspirate, blood, bronchoalveolar lavage, pus, peritoneal fluid, and cerebrospinal fluid, from hospitalized patients in different clinical departments. This review evaluated long-term trends in antimicrobial resistance profiles of A. baumannii and P. aeruginosa strains circulating in various regions of Romania. The findings revealed both temporal variability in resistance rates within comparable intervals and differences across distinct time periods. These long-term trends underscore the need for sustained national surveillance systems, harmonized reporting practices, and reinforced antimicrobial stewardship programs.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.